Patiëntenmateriaal
NovAssist ® - Patient Support Program Cosentyx ® NovAssist is a support program for your patients treated with Cosentyx ® . This program will help them, according to their needs and through...
NovAssist ® - Patient Support Program Cosentyx ® NovAssist is a support program for your patients treated with Cosentyx ® . This program will help them, according to their needs and through...
KESIMPTA ® offers the flexibility of a self-administered B-cell therapy 1
After initial dosing, KESIMPTA ® 20 mg is administered (sc) once monthly 1 ...
Kesimpta provides significant reduction in relapses of up to nearly 60% vs teriflunomide in RMS patients 1,2
ARR : Relative reduction in annualized relapses
Kesimpta shows a profound reduction...
B-cells play a central role in the pathogenesis of MS 2
KESIMPTA ® (ofatumumab) is a fully human anti...
Kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features 1
Both newly diagnosed patients and patients switching from...
Kesimpta ® is reimbursed in Belgium for adult patients with clinically proven relapsing multiple sclerosis (RMS) who meet the following criteria* :
The patient has highly active relapsing multiple sclerosis or
The patient...
A demonstrated safety and tolerability profile 2
Rate of infections between KESIMPTA ® and teriflunomide was comparable 1
1. Kesimpta...
1. Mayzent SmPC. 2. Kappos L, Bar-Or A, Cree BAC, et al. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND...
MAYZENT® is proven to work on symptoms associated with inflammation and neurodegeneration 1,2,3,4,5*
†Exploratory end point. 1 * In EXPAND, a...